ICU Medical Total Assets 2006-2019 | ICUI

ICU Medical total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • ICU Medical total assets for the quarter ending March 31, 2019 were $1.613B, a 8.07% increase year-over-year.
  • ICU Medical total assets for 2018 were $1.585B, a 5.91% increase from 2017.
  • ICU Medical total assets for 2017 were $1.497B, a 112.43% increase from 2016.
  • ICU Medical total assets for 2016 were $0.705B, a 12.42% increase from 2015.
ICU Medical Annual Total Assets
(Millions of US $)
2018 $1,585
2017 $1,497
2016 $705
2015 $627
2014 $541
2013 $500
2012 $429
2011 $361
2010 $310
2009 $309
2008 $283
2007 $243
2006 $244
2005 $205
ICU Medical Quarterly Total Assets
(Millions of US $)
Q1 2019 $1,613
Q4 2018 $1,585
Q3 2018 $1,545
Q2 2018 $1,526
Q1 2018 $1,493
Q4 2017 $1,497
Q3 2017 $1,523
Q2 2017 $1,487
Q1 2017 $1,473
Q4 2016 $705
Q3 2016 $689
Q2 2016 $663
Q1 2016 $636
Q4 2015 $627
Q3 2015 $610
Q2 2015 $570
Q1 2015 $554
Q4 2014 $541
Q3 2014 $528
Q2 2014 $520
Q1 2014 $506
Q4 2013 $500
Q3 2013 $469
Q2 2013 $452
Q1 2013 $438
Q4 2012 $429
Q3 2012 $413
Q2 2012 $393
Q1 2012 $376
Q4 2011 $361
Q3 2011 $344
Q2 2011 $346
Q1 2011 $329
Q4 2010 $310
Q3 2010 $300
Q2 2010 $287
Q1 2010 $287
Q4 2009 $309
Q3 2009 $310
Q2 2009 $299
Q1 2009 $294
Q4 2008 $283
Q3 2008 $270
Q2 2008 $260
Q1 2008 $247
Q4 2007 $243
Q3 2007 $247
Q2 2007 $257
Q1 2007 $249
Q4 2006 $244
Q3 2006 $236
Q2 2006 $228
Q1 2006 $215
Q4 2005 $205
Q3 2005 $192
Q2 2005 $186
Q1 2005 $173
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.188B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33